Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian Stock Markets open on a firm note
Wed, 15 Jul 09:30 am

The major Asian stock markets have opened the session on a mixed note with markets in Hong Kong (down 0.48 %) and China (down 2.40%) leading the losses. However, markets in Japan are trading in the green, up by 0.4%. US and European stock markets closed their session on an encouraging note yesterday. The rupee is trading in green at 63.9 per US dollar.

Indian stock markets today have opened on a firm note with positive cues from the global peers.BSE-Sensex is trading up by 122 points (up 0.44%) and NSE-Nifty is trading up by 35 points (up 0.39%). S&P BSE Midcap and S&P BSE Smallcap index indices are trading up by 0.36% and 0.62% respectively. Buying interest is seen is pharmaceutical and Information Technology (IT) sector.

Stocks in automobile sector are trading on a mixed note with Force Motors Ltd leading the pack of winners . However, Eicher Motors led the losses. Jaguar Land Rover (JLR), the UK subsidiary of Tata Motors has cut the price of its premium brand Range Rover Evoque in China. It is worth mentioning here that China is the biggest market for JLR. The price of the base model for instance is now down 11%. JLR produces the Evoque sports utility vehicle in Jiangshu province and operates in China in a joint venture with local auto maker Chery. China's contribution to JLR's overall sales fell to 23.5% in the three months to March, from 29.6% a year ago. Sales fell 20% to 23,526 vehicles in the same quarter, compared with a 36% increase in the year-ago quarter. Stock of Tata Motors is trading up by 0.06%.

Stocks in pharmaceutical sector are trading on a positive note with Elder Pharma and IPCA Labs leading the winners. As per a leading financial daily, Lupin Ltd is planning to making the highest R&D spend in the pharma industry. As per the management, the company will spend 10% of its turnover on R&D soon. Currently, R&D spend is at 8.5% of sales. In comparison, the average R&D spend for the industry is around 5-7% of sales. The management has declined to share details of the expansion in the R&D budget as of now. A focus on R&D is likely to help the company move up the value chain from generic business and getting into specialty business.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Stock Markets open on a firm note". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.